financetom
Business
financetom
/
Business
/
Ralph Lauren names insider Picicci as CFO, forecasts dull annual revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ralph Lauren names insider Picicci as CFO, forecasts dull annual revenue
May 23, 2024 5:53 AM

(Reuters) - Ralph Lauren ( RL ) on Thursday forecast annual revenue growth below market expectations and named insider Justin Picicci as its chief financial officer, effective immediately.

The apparel maker's shares, which have risen about 16% so far this year, were down 4.5% in premarket trade after the company also forecast current-quarter revenue growth below estimates.

Demand for pricier apparel in the United States has been choppy as consumers become increasingly particular about quality, style and value on their stressed discretionary budgets.

Ralph Lauren ( RL ), much like its peers in the apparel space, resorted to promotions in markets like the United States in order to appeal to a more price-sensitive lower-income consumer.

The company expects annual revenue to rise in low-single digits, centering on about 2% to 3%, below market expectations of a 3.98% increase to $6.89 billion, as per LSEG data.

Ralph Lauren's ( RL ) wholesale business has come under pressure in the United States as retailers and department stores limit orders while they face the brunt of weak demand from a cautious consumer.

Wholesale revenue in Ralph Lauren's ( RL ) biggest market, North America, fell 2% in the quarter following a 15% fall in the prior quarter.

"We continue to evaluate our brand presence on a door-by-door basis, resulting in approximately 20 department store exits completed in the region (North America) this fiscal year," the company said.

It also forecast first-quarter revenue to rise slightly, against expectations of a 2.82% increase to $1.54 billion.

However, the company's fourth-quarter revenue of $1.57 billion edged past estimates of $1.56 billion, benefiting from robust demand in its direct-to-consumer channel in Europe and Asia.

Picicci, who most recently served as Ralph Lauren's ( RL ) Enterprise CFO, succeeds Jane Nielsen. Nielsen joined the company as CFO in 2016, and took on the role of chief operating officer as well in 2019. She will remain as the apparel maker's COO.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Uber Explored Possible Bid For Expedia In 'Super App' Growth Push -  FT
BRIEF-Uber Explored Possible Bid For Expedia In 'Super App' Growth Push - FT
Oct 16, 2024
Oct 16 (Reuters) - * UBER EXPLORED POSSIBLE BID FOR EXPEDIA IN 'SUPER APP' GROWTH PUSH - FT Source text for Eikon: https://tinyurl.com/22k9lwp7 Further company coverage: ...
Boeing fine-tunes job cuts as major buyer slams 777X jet delay
Boeing fine-tunes job cuts as major buyer slams 777X jet delay
Oct 16, 2024
* Boeing ( BA ) plans series of meetings on job cuts, sources say * Jobs plan expected to include involuntary departures * Emirates Airline president slams new 777X delivery delay * Shares down 1.7% in pre-trading Oct 14 (Reuters) - Boeing ( BA ) faces a crucial test with employees, customers and investors after announcing 10% job cuts and...
Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program
Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program
Oct 16, 2024
05:48 PM EDT, 10/16/2024 (MT Newswires) -- Minerals Technologies ( MTX ) said Wednesday it increased its regular quarterly dividend by 10% to $0.11 per share, payable on Dec. 5 to stockholders of record on Oct. 31. The company also said it has been authorized by its board to buy back $200 million of its shares. ...
BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients
BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients
Oct 16, 2024
08:25 AM EDT, 10/14/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Monday a study of berotralstat, which it markets under the brand name of Orladeyo, showed a significant reduction in hospitalizations, emergency room visits, and use of on-demand therapies for patients with hereditary angioedema in the US. The company said that the study of berotralstat will be presented...
Copyright 2023-2026 - www.financetom.com All Rights Reserved